Cargando…
Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study
Autores principales: | Gotschall, Jeromy W., Major, C. Kendall, Jacobs, Linda A., Blauch, Abigail, Pucci, Donna, Palmer, Steven C., Mamtani, Ronac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931533/ https://www.ncbi.nlm.nih.gov/pubmed/36816152 http://dx.doi.org/10.1002/bco2.204 |
Ejemplares similares
-
Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
por: Narayan, Vivek, et al.
Publicado: (2016) -
Health behaviors among head and neck cancer survivors
por: McMenamin, Erin, et al.
Publicado: (2023) -
The Determinants of Salivary Cotinine Concentration in Smokeless Tobacco Users
por: Mahmoodabad, Sayed Saeed Mazloomy, et al.
Publicado: (2019) -
Effect of Sample Storage Conditions on Measurements of Salivary Cotinine Levels
por: Leite, Fábio Renato Manzolli, et al.
Publicado: (2020) -
Comparison of Salivary Cotinine Concentrations in Male Smokers and Smokeless Tobacco Users
por: Honarmand, Marieh, et al.
Publicado: (2018)